GLP1-Receptor Agonists for Prostate Cancer Treatment
Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
- Age
- 18 and older
- Sex
- Male
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Hamilton Health Sciences Corporation · Other
This trial is looking for men with prostate cancer who are receiving treatment to lower testosterone. Participants will take a medication called a GLP-1 receptor agonist to see how it affects their condition.
You may be able to join if
- I have been diagnosed with prostate cancer.
- I am receiving or plan to receive androgen deprivation therapy.
- I have a higher body weight.
You may not be able to join if
- I have type 1 diabetes.
- I am taking a GLP-1 receptor agonist.
- I am under 18 years old.
- I have a history of pancreatitis.
- I have a personal or family history of medullary thyroid cancer.
- I have multiple endocrine neoplasia type 2.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityGAIN PC CONTROL is a study investigating Glucagon-Like Peptide-1 Receptor Agonists in men with prostate cancer who are being treated with androgen deprivation therapy.
Loading trial locations…